Mapping large numbers of results may take a few moments.
|Company StrideBio Inc.||Activity: Research and Development||Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs).||Location Research Triangle Park|
|Company BioCytics Inc.||Activity: Research and Development||Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute.||Location Huntersville|
|Company Cellectis||Activity: Production and Manufacturing||Company Description Cellectis develops blood and bone marrow cancer cell therapies. The Raleigh location is its North American manufacturing plant.||Location Raleigh|
|Company Life Edit Therapeutics||Activity: Research and Development||Company Description Life Edit Therapeutics leverages its bioinformatic pipeline to identify novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships.||Location Morrisville|
|Company Locus Biosciences Inc.||Activity: Research and Development||Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed.||Location Morrisville|
|Company Twin City Bio LLC||Activity: Production and Manufacturing||Company Description Twin City Bio manufactures cell therapy products that use a patient's own cells to restore damaged kidney tissues by engrafting into, repairing or replacing damaged tissues or organs.||Location Winston-Salem|